
March 5 (Reuters) - Richter Gedeon Vegyeszeti Gyar Nyrt's CEO Gabor Orban:
COMPANY'S NEW LONG-TERM STRATEGY DOES NOT TAKE POSSIBLE U.S. TARIFFS ON EUROPEAN PRODUCTS INTO ACCOUNT AS DETAILS OF TARIFF PLANS ARE NOT YET KNOWN
MOST OF RICHTER'S INCOME FROM U.S. COMES FROM ROYALTIES AND ACTIVE INGREDIENTS, WHICH MEANS POSSIBLE TARIFFS WILL HAVE LESS ADVERSE EFFECT ON RICHTER THAN ON THE ENTIRE PRAMACEUTICAL SECTOR
POSSIBLE U.S. TARIFFS ON EUROPEAN PRODUCTS COULD AFFECT ITS WOMENS HEALTHCARE AND BIOTECHNOLOGY SALES IN THE LONG TERM